Home Page - Abzena

Abzena provides technologies and complementary services across Biology, Chemistry and Manufacturing.


About Us Contact Us

Abzena announces a research and licence agreement with Tmunity Therapeutics

a clinical stage T cell therapy company and a leader in the development of new Chimeric Antigen Receptor T Cell (CAR-T) therapies for the treatment of solid and hematological cancers

Read More

Release of first GMP drug substance for an ABZENA Inside product manufactured by Abzena

The manufacture of this product took place at Abzena’s site in San Diego, CA but utilised significant bioanalytics and bioassay expertise from Abzena’s Cambridge, UK site including product characterisation, binding, potency and stability assays.

Read More

Abzena and Telix sign licence agreement for Abzena’s Prostate-Specific Membrane Antigen Antibodies

Under the terms of the Agreement, Abzena has granted Telix an exclusive worldwide, royalty bearing, sub-licensable licence to its prostate-specific membrane antigen (‘PSMA’) antibodies in the field of radio-immunoconjugation.

Read More

Technologies and Solutions

Abzena provides proprietary technologies and complementary solutions to organisations involved in the development of biopharmaceutical products.

Latest News and Events

Abzena presents its latest research and exhibits at events all over the world.
Find out where we are next and our latest news below.

Load More

Resources and Downloads

Find our latest videos, brochures and fact sheets in our resources section.

Download our Brochure

Technology & Solutions Brochure

Download File

Antibody drug conjugates of cleavable amino-alkyl and aryl maytansinoids

Natural products have been used for many medicinal purposes for centuries. Antibody drug conjugates (ADCs)…

Read More

Cell Line Development Lab Tour

Abzena has over 10 years experience in Cell Line Development for customers and has completed…

View All Resources